Stephen Balinandi
Overview
Explore the profile of Stephen Balinandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bakamutumaho B, Juma J, Clancey E, Nyakarahuka L, Situma S, Odinoh R, et al.
medRxiv
. 2025 Jan;
PMID: 39867400
Introduction: Recent Rift Valley fever (RVF) epidemiology in eastern Africa region is characterized by widening geographic range and increasing frequency of small disease clusters. Here we conducted studies in southwestern...
2.
Balinandi S, Mulei S, Whitmer S, Nyakarahuka L, Cossaboom C, Shedroff E, et al.
PLoS Negl Trop Dis
. 2024 Oct;
18(10):e0012595.
PMID: 39413127
Background: In September 2022, Uganda experienced an outbreak of Sudan virus disease (SVD), mainly in central Uganda. As a result of enhanced surveillance activities for Ebola disease, samples from several...
3.
Kainulainen M, Harmon J, Karaaslan E, Kyondo J, Whitesell A, Twongyeirwe S, et al.
J Med Virol
. 2024 Oct;
96(10):e29946.
PMID: 39370872
Ebola disease (EBOD) in humans is a severe disease caused by at least four related viruses in the genus Orthoebolavirus, most often by the eponymous Ebola virus. Due to human-to-human...
4.
Cohen C, Balinandi S, Kuehne A, Rock M, Bonagofski L, Ricks K, et al.
J Infect Dis
. 2024 Sep;
PMID: 39248523
Evaluating the adaptive immune responses to natural infection with Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) in human survivors is critical to the development of medical countermeasures. However, the correlates of...
5.
Shin O, Monticelli S, Hjorth C, Hornet V, Doyle M, Abelson D, et al.
Cell Rep
. 2024 Jul;
43(7):114502.
PMID: 39002130
Crimean-Congo hemorrhagic fever virus can cause lethal disease in humans yet there are no approved medical countermeasures. Viral glycoprotein GP38, exclusive to Nairoviridae, is a target of protective antibodies and...
6.
Waltenburg M, Kainulainen M, Whitesell A, Nyakarahuka L, Baluku J, Kyondo J, et al.
Vaccine
. 2024 Jun;
42(22):126031.
PMID: 38880693
Background: The rVSVΔG-ZEBOV-GP Ebola vaccine (rVSV-ZEBOV) has been used in response to Ebola disease outbreaks caused by Ebola virus (EBOV). Understanding Ebola knowledge, attitudes, and practices (KAP) and the long-term...
7.
Komakech A, Whitmer S, Izudi J, Kizito C, Ninsiima M, Ahirirwe S, et al.
BMC Infect Dis
. 2024 May;
24(1):520.
PMID: 38783244
Background: On 20 September 2022, Uganda declared its fifth Sudan virus disease (SVD) outbreak, culminating in 142 confirmed and 22 probable cases. The reproductive rate (R) of this outbreak was...
8.
Anywaine Z, Hansen C, Warimwe G, Abu-Baker Mustapher G, Nyakarahuka L, Balinandi S, et al.
Virol J
. 2024 May;
21(1):104.
PMID: 38702807
Background: Rift Valley fever (RVF) is a zoonotic viral disease of increasing intensity among humans in Africa and the Arabian Peninsula. In Uganda, cases reported prior to 2016 were mild...
9.
Shin O, Monticelli S, Hjorth C, Hornet V, Doyle M, Abelson D, et al.
bioRxiv
. 2024 Mar;
PMID: 38496658
Crimean-Congo hemorrhagic fever virus can cause lethal disease in humans yet there are no approved medical countermeasures. Viral glycoprotein GP38, unique to , is a target of protective antibodies, but...
10.
Okek E, Masembe F, Kiconco J, Kayiwa J, Amwine E, Obote D, et al.
PLoS One
. 2024 Jan;
19(1):e0287272.
PMID: 38265993
Background: Significant milestones have been made in the development of COVID19 diagnostics Technologies. Government of the republic of Uganda and the line Ministry of Health mandated Uganda Virus Research Institute...